Dr. Li is a member of the Translational Therapeutics Program at the OSUCCC – James and the founding director of the Institute for Immuno-Oncology (IIO), which is dedicated to transforming the OSUCCC – James into a leader in basic and clinical immunology research, including prevention and survivorship.
Yiping Yang, MD, PhD
Dr. Yang is the director of the Division of Hematology and a nationally recognized expert in cancer immunology and immunotherapy.
Ephraim Ansa-Addo, PhD
Dr. Ansa-Addo specializes in regulatory T cells.
Kenneth Oestreich, PhD
Dr. Oestreich focuses on follicular helper T cells.
Immune Monitoring and Discovery
Lynn O'Donnell, PhD
Dr. O'Donnell is an associate professor of Internal Medicine. Her research interests novel cellular therapies for malignancies and regenerative medicine, translational development, GMP manufacturing, and IND and IDE submissions for FDA.